This statistic shows the chronic hepatitis B therapeutics sales in 2014 and 2024, by major market. Sales for chronic hepatitis B therapeutics in the U.S. market were some 773 million U.S. dollars in 2014.
Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024
(in million U.S. dollars)
Characteristic
2014
2024*
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
All data is based on primary research interviews and surveys conducted with key
opinion leaders (KOLs) and high-prescribing physicians in the countries
included in this report.
* Forecast.
** EU5: Five major European pharmaceutical markets (France, Germany,
Italy, Spain, and UK).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
GlobalData. (January 1, 2016). Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. "Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars)." Chart. January 1, 2016. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. (2016). Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData. "Chronic Hepatitis B Therapeutics Sales in Selected Major Markets in 2014 and 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/
GlobalData, Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/ (last visited August 25, 2024)
Chronic hepatitis B therapeutics sales in selected major markets in 2014 and 2024 (in million U.S. dollars) [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648515/market-sales-for-chronic-hepatitis-b-therapeutics-by-market/